Nakamoto Inc. Explains Role of Chief Medical Officer Amid Financial Scrutiny

Nakamoto Inc. (NAKA) has clarified the presence of a Chief Medical Officer, attributing it to its origin as KindlyMD before merging with Nakamoto Holdings in 2025. The company faces financial challenges including a $238 million net loss and significant shareholder dilution.

By Lockridge Okoth Mon, May 25, 2026 at 12:28 AM GMT+3 2 min read · Yahoo Finance ·

Nakamoto Inc. Explains Role of Chief Medical Officer Amid Financial Scrutiny

Tickers: $NAKA

Topics: Bitcoin Nasdaq listing reverse merger shareholder dilution treasury company

Read the full article at Yahoo Finance

More World news